
David Linehan
CEO of URMC · University of Rochester Medicine
Credentials: · · · · ·
History
PresentSchool of Medicine and Dentistry · University of Rochester
PresentSchool of Medicine and Dentistry · University of Rochester Medicine
- 1998–2001
Cancer Center
- 1995–1998
- 1990–1995
1982–1986
Research
The Journal of Immunology · 2002 · Last of 11 authors · 1,156 citations
Cancer Research · 2014 · 1,113 citations
Cancer Research · 2013 · 810 citations
- SS
48 papers

48 papers

20 papers

18 papers · 3 as a fellow

16 papers

12 papers · 9 as a resident
- RP
12 papers · 9 as a resident

10 papers · 4 as a resident
Grants
- 2025–2030
University of Rochester Wilmot Cancer Institute Support Grant
National Cancer Institute · P30
Project lead · $211.5K · University of Rochester
- 2021–2027
Repolarizing the Tumor and Metastatic Microenvironments to Treat Patients with Pancreatic Cancer
National Cancer Institute · R01
PI · $1.6M · University of Rochester
- 2013–2024
National Cancer Institute · R01
Contact PI · $3.6M · University of Rochester
- 2008–2011
A Resource for Biomedical Mass Spectrometry
National Center for Research Resources · P41
Project lead · $39.9K · Washington University
Clinical trials
- 2009–2013
Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas Cancer
Principal investigator · Terminated · Phase 1
Washington University School of Medicine
- 2007–2011
Principal investigator · Terminated · Phase 2
Washington University School of Medicine
- 2002–2009
Chemotherapy and Radiation Following Pancreatic Surgery
Principal investigator · Completed · Phase 2
Washington University School of Medicine


